Dr. Renata Mangione received her Master’s degree in “Health and Cellular-Molecular Biology”  from the University of Catania. She then had a 12-month continuous collaboration contract at  the Institute of Biochemistry and Clinical Biochemistry at Università Cattolica del Sacro Cuore  in Rome. Winner of a PhD position in “Basic Biomedical Sciences and Public Health” (“Studies  of Biological Samples via Platforms- Oomics,”). She served as a PhD student at the same UCSC  Institute. 

In 2022, during the second year of her Ph.D., for a period of 10 months, she was a “Visiting  Researcher” at the École Polytechnique Fédérale de Lausanne (EPFL), as part of the research  period abroad stipulated by the Ph.D. itself, focusing her study on the biochemical alterations  of agerelated degenerative muscle diseases, as an experimental study included in her Ph.D.  research project. In the scientific-experimental field, she has gained experience in the following  fields: – energy metabolism and mitochondrial dysfunction in head injury and concussion (in  animal and human); – evaluation of the efficacy of innovative pharmacological treatments for  the treatment of head injury and ALS; – research of tissue and circulating biomarkers in  neurodegenerative diseases; study of biochemical and molecular mechanisms and search for  biomarkers for male and female infertility; – study of metabolic alterations in tumor cells; – biomarkers research and diagnosis of specific metabolic and dating diseases (IEM); – evaluation of the efficacy of CRISPR-CAS9 as a possible gene therapy to counteract the  progression of age-related muscle degenerative diseases. 

During her research activity, Dr. Mangione collaborated with: – Institute of Inflammation and  Aging, University of Birmingham, UK (Prof. Ann Logan and Antonio Belli); – Tikomed AB, Viken,  Sweden (Dr. Lars Bruce); – Neuroscience and Ophthalmology Group, School of Clinical and  Experimental Medicine, College of Medical and Dental Sciences, University of Birmingham, UK  (Dr. Valentina Di Pietro); – Biotechnology and Bioengineering group, École Polytechnique  Fédérale de Lausanne (EPFL), Lausanne, Switzerland (Prof. Johan Auwerx and Dr. Martin  Wohlwend); – Section of Neurosurgery, Department of Emergency and Urgency, S.  Eugenio/CTO Hospital, Rome, Italy (Prof. Stefano Signoretti); – Department of Biomedical and  Biotechnological Sciences, University of Catania, Catania, Italy (Profs. Giuseppe Lazzarino,  Angela Maria Amorini, Giovanni Li Volti). – Department of Biomedical and Biotechnological  Sciences, University of Catania, Catania, Italy (Prof. Daniele Tibullo, Dr. Cesarina Giallongo) As  of October 2023, he held the position of Adjunct Lecturer for the Disciplinary Scientific Area  BIO/10- General Biochemistry, at UniCamillus – Saint Camillus International University of  Health and Medical Sciences, Corso Di Laurea Magistrale in Medicina e Chirurgia, Venice  campus. 

From October 2024 she is Fixed-term Researcher L.240 / 10 type A, SSD BIO / 10 at UniCamillus  – Saint Camillus International University of Health and Medical Sciences, Rome, Italy.

UniCamillus Researcher.